Related Experiment Video
Updated: Aug 26, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Sudden cardiac death
Eduardo S Antezano1, Mauricio Hong
1Division of Cardiology, M/C 7872, University of Texas Health Science Center, San Antonio, TX 78229, USA.
Insights
Sudden cardiac death (SCD) prevention strategies have advanced, particularly for high-risk patients. Implantable cardioverter-defibrillators offer proven benefits for both primary and secondary SCD prevention in selected individuals.
Area of Science:
- Cardiology
- Electrophysiology
- Preventive Medicine
Background:
- Sudden cardiac death (SCD) from ventricular tachyarrhythmias is a major cause of mortality in the US.
- Associated conditions include coronary artery disease, cardiomyopathies, and primary electrical disorders.
- Risk stratification and management protocols for SCD are continually evolving.
Purpose of the Study:
- To present an evidence-based approach for the primary and secondary prevention of sudden cardiac death.
- To review current strategies for evaluating and managing patients at risk for SCD.
- To highlight the role of implantable cardioverter-defibrillators in SCD prevention.
Main Methods:
- Review of recent clinical trials and guidelines.
- Evidence-based analysis of patient selection for defibrillator implantation.
- Focus on both primary prevention (at-risk patients) and secondary prevention (SCD survivors).
Main Results:
- Clinical trials demonstrate significant benefit from implantable cardioverter-defibrillators in appropriately selected patients.
- Established guidelines support the use of defibrillators for both primary and secondary prevention.
- An organized, evidence-based approach improves patient outcomes.
Conclusions:
- Implantable cardioverter-defibrillators are a cornerstone in the prevention of sudden cardiac death.
- Personalized, evidence-based strategies are crucial for managing patients at risk of SCD.
- Continued research and guideline updates are essential for optimizing SCD prevention.
Abstract:
Sudden cardiac death (SCD) due to ventricular tachyarrhythmias is a leading cause of death in the United States. This phenomenon is associated with coronary artery disease, valvular heart disease, nonischemic cardiomyopathies, congenital heart disease, primary electrical abnormalities, autonomic nervous system abnormalities, and other less common disorders. Evaluation and management of patients at risk for SCD (primary prevention) and of patients who have survived at least 1 episode of SCD (secondary prevention) have evolved in recent years because clinical trials have shown consistent benefit from implantation of cardioverter-defibrillators in appropriately selected patients. An evidence-based approach to primary and secondary prevention of SCD is presented.
Related Concept Videos
Introduction Cardiac Emergencies
Coronary Artery Disease III: Clinical Manifestations
Cardiopulmonary Resuscitation III: AED Use
Acute Coronary Syndrome I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
